A Practical Guide to the Safety and Monitoring of New IBD Therapies
Author:
Affiliation:
1. Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA
Funder
National Institutes of Health
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,Immunology and Allergy
Link
http://academic.oup.com/ibdjournal/article-pdf/25/5/831/28322327/izy313.pdf
Reference78 articles.
1. Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREAT™ registry;Lichtenstein;Am J Gastroenterol,2012
2. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study;Fidder;Gut,2009
3. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases;Grijalva;JAMA,2011
4. A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease;Lichtenstein;Am J Gastroenterol,2012
5. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review;Dulai;Clin Gastroenterol Hepatol,2014
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis;Frontiers in Cellular and Infection Microbiology;2023-12-08
2. Choosing Therapy for Moderate to Severe Crohn’s Disease;Journal of the Canadian Association of Gastroenterology;2023-09-22
3. HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients;Inflammatory Bowel Diseases;2023-07-18
4. Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies;Inflammatory Bowel Diseases;2023-07-14
5. Crohn’s disease and breast cancer: a literature review of the mechanisms and treatment;Internal and Emergency Medicine;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3